Literature DB >> 12757862

Molecular pathways in myocardial development: a stem cell perspective.

Mark J Solloway1, Richard P Harvey.   

Abstract

The heart has long been considered to adapt to increased work or pathology through the cellular growth process of hypertrophy. However, recent evidence for the existence of endogenous stem cells and regenerative capacity in the adult heart has given new impetus to the quest for cell therapies for heart failure, which remains the number one killer in Western cultures. The molecular cues driving cardiac development are now being explored in detail and will come into sharp focus as regimes for stem cell differentiation and efforts to augment endogenous regeneration are trialed. This review briefly outlines the current state of knowledge on the molecular basis of the four modalities of myogenesis that have been identified in the developing vertebrate heart. Stem cell-mediated myogenic repair in the heart represents a fifth modality, and an exciting frontier with basic and practical implications that remain to be explored.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12757862     DOI: 10.1016/s0008-6363(03)00286-4

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  26 in total

1.  FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes.

Authors:  Nathalie Rosenblatt-Velin; Mario G Lepore; Cristina Cartoni; Friedrich Beermann; Thierry Pedrazzini
Journal:  J Clin Invest       Date:  2005-06-09       Impact factor: 14.808

Review 2.  Stem cell treatment of the heart: a review of its current status on the brink of clinical experimentation.

Authors:  Paolo Angelini; Roger R Markwald
Journal:  Tex Heart Inst J       Date:  2005

3.  Multipotent stem cells in cardiac regenerative therapy.

Authors:  Ravi Karra; Sean M Wu
Journal:  Regen Med       Date:  2008-03       Impact factor: 3.806

Review 4.  microRNAs and muscle disorders.

Authors:  Jian-Fu Chen; Thomas E Callis; Da-Zhi Wang
Journal:  J Cell Sci       Date:  2009-01-01       Impact factor: 5.285

5.  Multipotent progenitor cells in regenerative cardiovascular medicine.

Authors:  Jason T Lam; Alessandra Moretti; Karl-Ludwig Laugwitz
Journal:  Pediatr Cardiol       Date:  2009-05-05       Impact factor: 1.655

6.  Irx4 identifies a chamber-specific cell population that contributes to ventricular myocardium development.

Authors:  Daryl O Nelson; Dexter X Jin; Karen M Downs; Timothy J Kamp; Gary E Lyons
Journal:  Dev Dyn       Date:  2014-03       Impact factor: 3.780

Review 7.  "The state of the heart": Recent advances in engineering human cardiac tissue from pluripotent stem cells.

Authors:  Dario Sirabella; Elisa Cimetta; Gordana Vunjak-Novakovic
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-10

8.  Mesenchymal stem cells are recruited to striated muscle by NFAT/IL-4-mediated cell fusion.

Authors:  Manja Schulze; Fikru Belema-Bedada; Antje Technau; Thomas Braun
Journal:  Genes Dev       Date:  2005-08-01       Impact factor: 11.361

9.  Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling.

Authors:  Sarika Saraswati; Maria P Alfaro; Curtis A Thorne; James Atkinson; Ethan Lee; Pampee P Young
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

10.  Origins and fates of cardiovascular progenitor cells.

Authors:  Sean M Wu; Kenneth R Chien; Christine Mummery
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.